Since 2003, the Ontario Pancreas Cancer Study (OPCS) has aimed to identify genetic, environmental, and lifestyle causes of pancreatic adenocarcinoma, the most common type of pancreas cancer. Results from this study will help us understand risk factors, patterns of inheritance, and discover possible genetic and biochemical markers of pancreas cancer. We are also interested in evaluating pancreas cancer screening techniques with the hope that, in the future, this disease may be detected at an early stage. The study identifies and contacts newly diagnosed patients with pancreas cancer from clinics at Princess Margaret Cancer Centre and the Toronto General Hospital. We also accept referrals to participate in our study.

The OPCS obtains information about family history, cancer treatment, and personal history/lifestyle from a questionnaire package that is provided to participants. This study may also involve collecting blood (or saliva), medical records, and any available tissue samples from previous biopsies or surgeries. These samples are used to investigate potential sources of genetic risk of pancreas cancer. Genetic counselling is available to every participant. If there is a family history of cancer, genetic counsellors provide information and make referrals for further genetic assessment and possibly genetic testing when appropriate.

The OPCS team greatly appreciates the participation of everyone involved. If you have any questions or would like to be involved with our research, please contact us at FGICR.MSH@sinaihealth.ca. You can also call our toll free number at 1-877-586-1559 and leave a message. We are happy to answer your questions.